May 9 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday its sales revenue edged up by an annual 0.3% in the first four months of 2018.
Domestic sales revenue added up 0.5% year-on-year in the January-April period, while exports increased 0.1%, the company said in a bourse filing.
In April alone, Sopharma's sales rose 12% year-on-year as exports grew 21%, while domestic sales added 1%.
The company did not disclose information about the volume of its sales or amount of sales revenue.
As at 12:40 CET on Wednesday, Sopharma shares traded 0.24% higher at 4.22 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)